IL17A and lung disorder: It has to be underlined, however, that the hypothesized antifibrotic role of IL-17A in SSc is not supported by experimental models of inflammatory/drug-induced fibrosis, in which IL-17A seems to induce fibrosis in both skin and lung disease (16, 17, 42, 43).